Dr. Kris Discusses The Imatinib Gist Clinical Trial

Dr. Kris Discusses the Imatinib GIST Clinical Trial

GIST: Assessing Response to Imatinib Therapy

Dr. Kris Discusses Available Targeted Therapies

Dr. Kris on the Crizotinib Clinical Trials

Dr. Singh Discusses Immunotherapy Study in GIST

Update on the treatment of GIST

Dr. Joensuu Discusses the Progress of GIST Treatments

What is new in GIST in the last 12 months?

Dr. Singh Discusses the Next Steps for Immunotherapy in GISTs

Dr. Singh Discusses Challenges for GIST

Dr. Kris on the RELAY Trial in EGFR+ NSCLC

Longer Adjuvant Imatinib Therapy Better in High-Risk GIST

MDedge: news and insights for busy physicians

Dr. George Demetri on blood test for cancer mutations | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

INVICTUS and INTRIGUE: investigating ripretinib in patients with advanced GIST

Managing BCR-ABL Inhibitor Associated Skin Rash

GIST Support UK - An Update on Clinical Trials - Dr Charlotte Benson - March 2018, London

Serum Imatinib (Gleevec) Levels Predict GIST Response

GIST Cancer UK - Generic Imatinib : The Cambridge Experience, Dr. Ramesh Bulusu at London April 2023

Mastering GIST treatment: Imatinib and other targeted therapy for gastrointestinal stromal tumors

Edusurg Clinics

What are the efficacy and safety considerations of imatinib therapy?

MediCom Oncology